Amol M. Takalkar, MD, MS, MBA, FACNM

Role

Nuclear Medicine
Specialty

Bile Duct (Biliary) Cancer Breast Cancer Colorectal Cancer Esophageal Cancer Liver Cancer Pancreatic Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2005

Titles & Roles

Professor, Department of Radiology and Imaging Sciences

Emory University School of Medicine

Education & Training

Education

Residency, Nuclear Medicine, 2005
Hospital of Univ of Pennsylvania
Internship, General Surgery, 2003
Lenox Hill Hospital
Medical Education, , 1999
B. J. Medical College

Board Certifications

Nuclear Medicine
American Board of Nuclear Medicine, 2005

View Current Clinical Trials


Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy Phase I/II/III Conditions GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NET Location Emory University Hospital Midtown

Title/Journal	Authors	Publication Date
Molecular Imaging of Breast Cancer Molecular Imaging and Therapy	VS Krishnaraju, H Singh, LT Hall, AM Takalkar, BR Mittal	08/11/2023
Molecular Imaging of Head and Neck Cancers Molecular Imaging and Therapy	S Jain, AM Takalkar, LT Hall	08/11/2023
Molecular Imaging of Hepatobiliary Cancers Molecular Imaging and Therapy	K Subramanian, P Aggarwal, LT Hall, H Singh, AM Takalkar, BR Mittal	08/11/2023
Molecular Imaging of Lung and Pleural Tumors Molecular Imaging and Therapy	T Sivathapandi, J Amalchandran, A Takalkar, LT Hall	08/11/2023
Molecular Imaging of Mediastinal Tumors Molecular Imaging and Therapy	J Amalachandran, A Takalkar, T Sivathapandi, LT Hall	08/11/2023
Molecular Imaging of Pediatric Lymphoma, Sarcomas, and Other Solid Tumors Molecular Imaging and Therapy	Y Mathur, K Shankar, H Veerwal, S Kumar, R Kumar, AM Takalkar, LT Hall	08/11/2023
Mickey Mouse Sign on Bone Scan: This Mouseketeer Rebels Against Paget Disease. Clinical nuclear medicine	FM Khan, B Chen, AM Takalkar	01/04/2022

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.